Sat, Aug 22, 2026
[Archive]
Articles In Press
Back to the articles list |
Back to browse issues page
Javid Nouri *1 
, Hossein Jahangard2 , Mona Pazhouhi3 , Cyrus Jalili3 , Houshang Nemati4 , Davood Rezazadeh4
, Hossein Jahangard2 , Mona Pazhouhi3 , Cyrus Jalili3 , Houshang Nemati4 , Davood Rezazadeh4
1- Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran. , nourijavid1@gmail.com
2- Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
3- Department of Anatomical Sciences, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
4- Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
2- Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
3- Department of Anatomical Sciences, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
4- Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
Abstract: (1 Views)
Background: Cancer remains a major global health challenge, and its development is closely associated with oxidative stress and chronic inflammation. Rosa canina (wild rose) has been traditionally used in Iranian medicine for its therapeutic properties, however, its anticancer and anti-inflammatory properties have not been comprehensively investigated. In this experimental study, the hydroalcoholic extract of Rosa canina fruit was evaluated for its antioxidant, anticancer, and anti-inflammatory activities.
Methods: Phytochemical screening, total phenolic content (TPC), total flavonoid content (TFC), and condensed tannins (CTC) were determined spectrophotometrically. Antioxidant activity was assessed by DPPH and ABTS radical scavenging assays. The cytotoxic effects were tested on HeLa, Hep3B, and HCT116 cancer cell lines using the MTT assay, while anti-inflammatory effects were evaluated on RAW 264.7 macrophages through nitric oxide (NO), prostaglandin E2 (PGE2), and tumor necrosis factor-alpha (TNF-α) assays.
Results: The extract showed high levels of alkaloids, terpenoids, polyphenols, and flavonoids. It demonstrated strong, concentration-dependent antioxidant activity in both DPPH and ABTS assays (p<0.05). Cell viability of cancer lines significantly decreased in a dose-dependent manner, while the production of NO, PGE2, and TNF-α in LPS-stimulated macrophages was significantly inhibited (p<0.05).
Conclusion: These findings suggest that the hydroalcoholic extract of Rosa canina fruit possesses remarkable antioxidant, anti-inflammatory, and anticancer properties, which may be attributed to its rich polyphenolic and flavonoid composition. Further studies, including in vivo investigations, are warranted to confirm its therapeutic potential against cancer and inflammatory diseases.
Methods: Phytochemical screening, total phenolic content (TPC), total flavonoid content (TFC), and condensed tannins (CTC) were determined spectrophotometrically. Antioxidant activity was assessed by DPPH and ABTS radical scavenging assays. The cytotoxic effects were tested on HeLa, Hep3B, and HCT116 cancer cell lines using the MTT assay, while anti-inflammatory effects were evaluated on RAW 264.7 macrophages through nitric oxide (NO), prostaglandin E2 (PGE2), and tumor necrosis factor-alpha (TNF-α) assays.
Results: The extract showed high levels of alkaloids, terpenoids, polyphenols, and flavonoids. It demonstrated strong, concentration-dependent antioxidant activity in both DPPH and ABTS assays (p<0.05). Cell viability of cancer lines significantly decreased in a dose-dependent manner, while the production of NO, PGE2, and TNF-α in LPS-stimulated macrophages was significantly inhibited (p<0.05).
Conclusion: These findings suggest that the hydroalcoholic extract of Rosa canina fruit possesses remarkable antioxidant, anti-inflammatory, and anticancer properties, which may be attributed to its rich polyphenolic and flavonoid composition. Further studies, including in vivo investigations, are warranted to confirm its therapeutic potential against cancer and inflammatory diseases.
Type of Study: Original Research Article |
Subject:
Life Science
Received: 2025/10/25 | Accepted: 2026/08/22
Received: 2025/10/25 | Accepted: 2026/08/22
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright Policy
Journal of Advances in Medical and Biomedical Research by Zanjan University of Medical Sciences is licensed under CC BY-NC 4.0
